Cumulative studies indicated that adult hippocampal neurogenesis might be involved in the action mechanism of antidepressant drugs and/or the pathophysiology of depression. Dopamine (DA) is involved in the regulation of motivation, volition, interest/pleasure, and attention/concentration, all of which are likely to be impaired in depressed patients. Several previous reports suggest that depression may often be accompanied by a relative hypodopaminergic state, and some DA receptor agonists are beneficial effects in the treatment for refractory and bipolar depression. In the present study, to clarify the direct effect of DA on neural progenitor cells, we examined the effect of DA on the proliferation of adult rat dentate gyrus-derived neural precursor cells (ADPs). In addition, we examined the effect of DA receptor agonists on adult rat hippocampal neurogenesis in vivo. Results showed that DA promoted the increase of ADPs via D1-like receptor and D1-like receptor agonist promoted the survival of newborn cells in the adult hippocampus. On the contrary, D2-like receptor agonist did not affect both proliferation and survival. These results suggested that DA might play, at least in part, a role in adult hippocampal neurogenesis via D1-like receptor and the activation of D1-like receptor has a therapeutic potential for depression.
In the adult mammalian brain, neurogenesis mainly occurs in two regions, subventricular zone (SVZ) situated through the lateral wall of the lateral ventricles and subgranular zone (SGZ) in the dentate gyrus (DG) of hippocampus (Kempermann, 2006) . Neural precursor cells (NPCs) reside in the SGZ proliferate, survive, and differentiate into neuron and glia. This differential step of neurogenesis is affected by many factors, including environment, stress, hormone and drugs (Dranovsky and Hen, 2006; Duman et al., 2001) . Stress of various kinds is considered to be a risk factor of depression, and decreases the proliferation of NPCs (Gould et al., 1997; Pham et al., 2003) . As a clinical therapeutic effect, chronic treatment with different classes of antidepressant drugs such as selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants (TCAs), and noradrenalin reuptake inhibitors increases the proliferation (Airan et al., 2007; Malberg et al., 2000; Santarelli et al., 2003) . It is also reported that suppression of hippocampal neurogenesis by the irradiation prevents anti-depressive effects induced by fluoxetine or imipramine treatment (Airan et al., 2007; Santarelli et al., 2003) . These results suggest that neurogenesis might be involved in the action mechanism of antidepressant drugs and/or the pathophysiology of depression. However, it remains unknown in detail how antidepressant drugs regulate adult hippocampal neurogenesis and how the modified neurogenesis shows anti-depressive effects. Dopamine (DA) is involved in the regulation of motivation, volition, interest/pleasure, and attention/concentration, all of which are likely to be impaired in depressed patients. Several previous reports suggest that depression may often be accompanied by a relative hypo-dopaminergic state (Papakostas, 2006) . Roy et al. (1985) reported lower cerebrospinal fluid of homovanilic acid, a chief metabolite of DA. Several neuroimaging studies showed increased D2/D3-receptor and decreased DA transporter bindings in some brain regions of depressive patients (D'Haenen and Bossuyt, 1994; Meyer et al., 2001; Shah et al., 1997) . Therefore, the dopaminergic system may be a target for the pharmacological treatment of depression. In fact, it has been reported that DA receptor agonists such as bromocriptine, pramipexole or the combination therapy of them with antidepressants may be beneficial effects in the treatment for refractory and bipolar depression (Aiken, 2007; Inoue et al., 1996 Inoue et al., , 2010 .
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